Researchers at the University of Zurich have modified a common respiratory adenovirus to enter tumor cells like a Trojan horse and deliver genes for a variety of treatments.

Iran PressEurope: These genes trick the tumor cells into producing therapeutic antibodies, causing them to be eliminated from the inside out, Futurism reported.

The futuristic approach could represent a major advance compared to chemo- or radiotherapy, as it doesn’t attack healthy cells.

The researchers are hoping their technique, called SHREAD (shielded, retargeted adenovirus), could even help with COVID-related therapies by allowing genes to be delivered straight to the lungs.

In fact, several COVID vaccines already being administered use adenoviruses, including the ones made by Johnson & Johnson and AstraZeneca.

“We trick the tumor into eliminating itself through the production of anti-cancer agents by its own cells,” said postdoctoral fellow Sheena Smith at UZH and development lead, in a statement.


Read more:

Iranian researcher suggests new way for brain cancer treatment

Dietary factors associate with mental health